Intrinsic Cardiac Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Intrinsic cardiac neurons (ICNs) are a population of neurons located within the heart itself that form the "little brain" of the heart. These neurons constitute the cardiac nervous system, which can operate independently of central nervous system input to modulate heart rate, contractility, and cardiac rhythm. While primarily studied in cardiovascular physiology, these neurons have emerging relevance to neurodegenerative diseases through autonomic dysfunction.
In neurodegeneration, particularly in Parkinson's disease and multiple system atrophy, cardiac autonomic dysfunction is a common non-motor symptom, reflecting pathology in both central and peripheral autonomic pathways including intrinsic cardiac neurons.
| Taxonomy |
ID |
Name / Label |
| Cell Ontology (CL) |
CL:0010020 |
cardiac glial cell |
- Morphology: cardiac glial cell (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
Intrinsic cardiac neurons are distributed throughout the heart:
- Atrial regions: Superior vena cava, pulmonary vein ostia
- Intracardiac ganglia: Clustered in specific regions
- AV node region: Atrioventricular ganglion
- Distribution: 10,000-50,000 neurons in human heart
ICNs exhibit varied morphology:
- Soma size: 15-50 μm diameter
- Cell types: Pseudounipolar, multipolar, Dogiel type II
- Processes: Extensive local connections
- Neurotransmitters: Cholinergic (parasympathetic), some nitrergic
Intrinsic cardiac neurons use:
- Acetylcholine: Primary parasympathetic transmitter
- Nitric oxide: Non-adrenergic, non-cholinergic (NANC)
- Vasoactive peptides: Substance P, CGRP
- ATP: Purinergic signaling
Key receptors include:
- Muscarinic M2/M3: ACh receptors
- Nicotinic: nAChR for synaptic transmission
- Adrenergic: α and β receptors for circulating catecholamines
- Purinergic: P2X, P2Y receptors
ICNs integrate multiple inputs:
- Central commands: From vagus and sympathetic nerves
- Sensory feedback: Cardiac stretch receptors
- Local signaling: Intracardiac reflexes
- Humoral modulation: Circulating factors
Functions include:
- Heart rate modulation: Negative chronotropic effects
- Contractility: Inotropic modulation
- Conduction: Dromotropic effects
- Rhythm stability: Anti-arrhythmic protection
Vagal control of ICNs:
- Vagus nerve input: Preganglionic fibers to ICNs
- Acetylcholine release: Activates muscarinic receptors
- Heart rate decrease: Reduced automaticity
- AV conduction delay: Protecting against tachycardia
Sympathetic modulation:
- Spinal input: Via middle cervical ganglia
- Norepinephrine release: β-adrenergic effects
- Positive chronotropy: Increased heart rate
- Enhanced contractility: Force modulation
Cardiac autonomic dysfunction in PD:
- Cardiac sympathetic denervation: Loss of noradrenergic innervation
- Orthostatic hypotension: Common non-motor symptom
- Reduced heart rate variability: Autonomic impairment
- Pathology spread: Includes peripheral autonomic nervous system
In MSA:
- Severe autonomic failure: Including cardiac dysfunction
- Lewy body pathology: In cardiac neurons
- Postganglionic involvement: Peripheral neuron loss
DLB cardiac involvement:
- Autonomic dysfunction: Common feature
- Lewy bodies: In cardiac sympathetic neurons
- Similar to PD: Cardiac sympathetic denervation
Cardiac effects:
- Cardiac denervation: Progressive loss
- Silent myocardial ischemia: Painless ischemia
- Resting tachycardia: Vagal loss
- Exercise intolerance: Impaired response
Cardiac pacing:
- Pacemaker implantation: For bradyarrhythmias
- ICD placement: For malignant arrhythmias
- CRT devices: Cardiac resynchronization
Autonomic modulation:
- Midodrine: For orthostatic hypotension
- Droxidopa: Norepinephrine prodrug
- Pyridostigmine: Enhance cholinergic transmission
- β-blockers: Heart rate control
Emerging therapies:
- Gene therapy: Autonomic pathway modulation
- Cell transplantation: Neural progenitors
- Device neuromodulation: Vagal stimulation
- Regenerative approaches: Nerve growth factors
](/mechanisms/cardiac-conduction-system)##